Adamant Biomedical Investments AG
Q4 2014 13F Holdings
- Locationzurich, V8
- Num holdings
101
- Value ($000)
$418,367
- Date Filed 02/13/2015
- Form type13F-HR
- CIK 0001542336
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2014 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
C CELGENE CORPORATION | COM | 151020104 | $20.82M | 5 % | 186,170 | ||
B BIOGEN IDEC INC | COM | 09062X103 | $18.08M | 4 % | 53,250 | ||
G GILEAD SCIENCES INC | COM | 375558103 | $17.00M | 4 % | 180,390 | ||
A AMGEN INC | COM | 031162100 | $15.13M | 4 % | 95,000 | ||
ACTAVIS PLC | SHS | G0083B108 | $13.28M | 3 % | 51,590 | ||
U UNITEDHEALTH GROUP INCORPORATED | COM | 91324P102 | $11.63M | 3 % | 115,000 | ||
MYLAN INC | COM | 628530107 | $11.27M | 3 % | 200,000 | ||
C CATAMARAN CORPORATION | COM | 148887102 | $10.73M | 3 % | 206,820 | ||
A ALEXION PHARMACEUTICALS INC | COM | 015351109 | $10.55M | 3 % | 57,000 | ||
M MEDTRONIC INC | COM | 585055106 | $8.77M | 2 % | 121,500 |
Rows Per Page
10
- 10
- 50
- 100